FDA Should Have Separate Consumer Website, Panelists Say At Risk Hearing
Executive Summary
FDA should launch a separate consumer website that serves as a one-stop shop for reliable and up-to-date drug risk and adverse event information, panelists suggested at a Dec. 7-8 FDA public hearing on the communication of drug safety information
You may also be interested in...
FDA Should Reassess Patient Information Sheet Proposal, NCPIE Says
FDA should rethink its proposal for agency-issued patient information sheets, National Council on Patient Information & Education Exec VP Ray Bullman said at a recent hearing on drug safety communications
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011